EUVIMEDEUVIMED entdecken
Crossref

Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk

Holly M Steininger, Kathryn E McCauley, Gabe E Braga, Andréanne Morin, Kristine E Lee, Cynthia M Visness, Douglas W Fadrosh, Matthew Dapas, George T O'Connor, Leonard B Bacharier, Katherine Rivera-Spoljaric, Meyer Kattan und 15 weitere

Journal of Allergy and Clinical Immunology · 2026

DOI: 10.1016/j.jaci.2026.05.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026. Verfasst von Holly M Steininger und 26 weiteren Autor:innen. Beteiligte Einrichtung: Benioff Center for Microbiome Medicine, Department of Medicine, University of California, San Francisco, Calif. Hauptthemen laut MEDLINE: Microbiota, Asthma, Respiratory Sounds, Membrane Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: NIH NIAID.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Single-nucleotide polymorphisms (SNPs) in the chromosome 17q12-q21 region and, independently, early-life nasal microbiota dominated by Moraxella, Streptococcus, or Haemophilus (MSH) increase risk of chronic wheeze and asthma development. OBJECTIVE: We sought to determine whether 17q12-q21 risk SNPs and nasal microbiota interact to modulate childhood wheeze risk. METHODS: Nasal wash samples from 12-month-old infants in 2 birth cohorts, COAST (Childhood Origins of Asthma; n = 180) and URECA (Urban Environment and Childhood Asthma; n = 139), underwent 16S ribosomal RNA variable region 4 sequencing. Nasal microbiota dominated by MSH or Corynebacterium, Dolosigranulum, Staphylococcus, or Bacillus (CDSB) were assessed. Paired blood was genotyped for 9 17q12-q21 risk SNPs. Logistic regression tested interactions between 17q12-q21 SNPs and MSH or CDSB on wheeze risk in the first 3 years of life. A549 lung epithelial cells, CRISPR-edited to encode the rs7216389 risk genotype (rs7216389TT) were compared to the heterozygous (rs7216389CT) line using bulk RNA sequencing. RESULTS: SNPs, particularly those in the ORMDL3 (rs8076131; odds ratio [OR]: 1.72; 95% CI: 1.09-2.71; Pint = .031) and GSDMB (rs2305480; OR: 1.72; 95% CI: 1.09-2.71; Pint = 0.042; and rs7216389; OR: 1.73; 95% CI: 1.09-2.70; Pint = .047) genes, interact with MSH microbiota to increase early-life wheeze risk (false discovery rate Pint = .016 for all), while interactions with CDSB reduce risk. A549 airway epithelial cells homozygous for rs7216389TT exhibited decreased expression of genes involved in antimicrobial responses and neutrophil recruitment and evidence increased microbial adherence compared with the heterozygous cell line. CONCLUSION: Airway microbiota interact with SNPs at the 17q12-q21 locus in genes involved in sphingolipid metabolism and intracellular antimicrobial responses, to modulate wheeze risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaAsthmaRespiratory SoundsMembrane ProteinsHumansPolymorphism, Single NucleotideFemaleInfantMaleGasderminsGenetic Predisposition to DiseaseChromosomes, Human, Pair 17Risk Factors

Stichwörter der Autor:innen

17q12-q21 risk lociAirway microbiotawheeze

Substanzen

GSDMB protein, humanORMDL3 protein, humanMembrane ProteinsGasdermins

Autor:innen und Institutionen

  • Benioff Center for Microbiome Medicine, Department of Medicine, University of California, San Francisco, Calif.
  • Department of Human Genetics, University of Chicago, Chicago, Ill.
  • Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wis.
  • Rho, Inc, Federal Research Operations, Durham, NC.
  • Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Ill.
  • Pulmonary Center, Boston University, Boston, Mass.

Förderung

  • NIH NIAID

Zitieren

APA

Steininger, H. M., McCauley, K. E., Braga, G. E., Morin, A., Lee, K. E., Visness, C. M., Fadrosh, D. W., Dapas, M., O'Connor, G. T., Bacharier, L. B., Rivera-Spoljaric, K., Kattan, M., Lemanske, R. F., Zoratti, E. M., Martinez, F. D., Gold, D. R., Hartert, T. V., Johnson, C. C., Miller, R. L., …, & CADRE Investigators (2026). Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.05.021

Vancouver

Steininger HM, McCauley KE, Braga GE, Morin A, Lee KE, Visness CM, et al. Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.05.021

BibTeX
@article{Steininger2026,
  author = {Steininger, Holly M and McCauley, Kathryn E and Braga, Gabe E and Morin, Andréanne and Lee, Kristine E and Visness, Cynthia M and Fadrosh, Douglas W and Dapas, Matthew and O'Connor, George T and Bacharier, Leonard B and Rivera-Spoljaric, Katherine and Kattan, Meyer and Lemanske, Robert F and Zoratti, Edward M and Martinez, Fernando D and Gold, Diane R and Hartert, Tina V and Johnson, Christine C and Miller, Rachel L and Seroogy, Christine M and Wood, Robert A and Togias, Alkis and Jackson, Daniel J and Gern, James E and Ober, Carole and Lynch, Susan V and CADRE Investigators, CADRE Investigators},
  title = {Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  doi = {10.1016/j.jaci.2026.05.021}
}
Kostenlos starten →